NCT00106158View on ClinicalTrials.gov

Safety Study of NY-ESO-1 Protein Vaccine to Treat Cancer Expressing NY-ESO-1

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

December 31, 2006

Conditions
Neoplasms
Interventions
BIOLOGICAL

protein vaccination

Trial Locations (1)

700-8558

Dept. of Immunology, Okayama University School of Medicine and Dentistry, Okayama

Sponsors
All Listed Sponsors
lead

Ludwig Institute for Cancer Research

OTHER